Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Mental Health

Increased Interleukin-6 Levels in Responders with Treatment-Resistant Depression After Bright Light Therapy

However, when patients were divided according to treatment response, IL-6 levels were increased in responders to BLT.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors measured serum interleukin-6 in 54 women with treatment-resistant depression before and after four weeks of bright light therapy, and compared them with 50 healthy controls. Overall IL-6 levels did not change significantly, but IL-6 rose in patients who responded to the light therapy. The study was small and limited to women, and the authors note IL-6 changes may be potential indicators of response rather than established markers.

Participants
104
Who or what was studied
Women with treatment-resistant depression (54 patients, median age 52.5) and healthy female controls (50, median age 44.5)
Limits stated in the abstract
The abstract describes a study limited to female participants and does not state a comparison group receiving a sham or placebo light condition.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Treatment-resistant depression (TRD) remains a challenge despite the growing number of interventions. Peripheral interleukin-6 (IL-6) levels have repeatedly been associated with both the presence and response to different treatments in TRD. There is currently no information available on the effects of bright light therapy (BLT) on serum IL-6 levels. This study assessed the effects of BLT on serum IL-6 levels in TRD patients. Serum IL-6 was determined at two points in TRD patients-at baseline and after 4 weeks of BLT-and at a single point in the healthy controls. Depression severity was measured by the Hamilton Rating Scale for Depression (HAMD)-17 and the Montgomery-Åsberg Depression Rating Scale (MADRS). The study included 104 females, 54 diagnosed with TRD (median age 52.5) and 50 healthy controls (median age 44.5). At baseline, patients had higher IL-6 levels than the controls. BLT treatment reduced HAMD-17 and MADRS scores. Serum IL-6 levels were not significantly affected by the 4 weeks of BLT. However, when patients were divided according to treatment response, IL-6 levels were increased in responders to BLT. The neuroinflammatory mechanism may be involved in the etiopathogenesis and the treatment of TRD, while changes in serum IL-6 levels may be potential indicators of response to treatment.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Depression, Bright light therapy. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies